Home > Insider Trading > Pds Biotechnology Corp > Profile

Pds Biotechnology Corp (PDSB)

Market is closed

Sector: Pharmaceutical Preparations

Insider Roster

Frank Bedu-Addo, President/Ceo, 2025-07-25
V. Kirk Shepard, Chief Medical Officer, 2025-07-25
D. Spencer Brown, Senior Vp, General Counsel, 2025-07-25

Frank Bedu-Addo, President/Ceo, 2025-07-25
V. Kirk Shepard, Chief Medical Officer, 2025-07-25
D. Spencer Brown, Senior Vp, General Counsel, 2025-07-25
Lars Boesgaard, Chief Financial Officer, 2025-07-25
Gregory Conn, Chief Scientific Officer, 2025-07-25
Stephan Toutain, Chief Operations Officer, 2025-07-25
W Otis Brawley, 2025-06-11
Kamil Ali-Jackson, 2025-06-11
Gene Gregory Freitag, 2025-06-11
Ilian Iliev, 2025-06-11
C. Stephen Glover, 2025-06-11
Richard Sykes, 2024-06-25
C Matthew Hill, Chief Financial Officer, 2023-01-06
Lauren Wood, Chief Medical Officer, 2023-01-06
Janetta Trochimiuk, Principal Accounting Officer, 2021-10-12
Seth Voorhees Van, Chief Financial Officer, 2021-06-17
N. Michael King, Interim Cfo, 2020-12-09
W Delyle Bloomquist, 2020-06-25
Andrew Saik, Chief Financial Officer, 2020-02-19
J James Loughlin, Director, 2019-07-01
Loch R. Macdonald, Director, 2019-03-18
J. Robert Spiegel, Director, 2019-03-18
Liam Ratcliffe, Director, 2019-03-18
Bradford W Middlekauff, Senior Vp, Gc And Secretary, 2019-03-18
A Brian Leuthner, President And Ceo, 2019-03-18
Isaac Blech, Director, 2019-03-18
A Rosemary Crane, Director, 2019-03-18
J Sol Barer, Director, 2019-03-18
Alyssa Wyant, Svp Regulatory Affairs, 2019-01-03
Ii N Albert Marchio, Chief Accounting & Adm Officer, 2018-12-31
J Herbert Faleck, Chief Medical Officer, 2018-12-31
G Kurt Conti, Director, 2018-03-30
Daniel Brennan, Chief Operating Officer, 2018-03-05
James Healy, Director, 2017-06-21
Alpaslan Yaman, V.p., Technical Ops. & Mfg., 2017-03-15
J. Andrew Einhorn, Chief Financial Officer, 2017-03-13
New Leaf Venture Partners, L.l.c., Director, 2016-06-24
New Leaf Venture Management Iii, L.l.c., Director, 2016-06-24
New Leaf Venture Associates Iii, L.p., Director, 2016-06-24
New Leaf Ventures Iii, L.p., Director, 2016-06-24
Renu Vaish, V.p., Global Reg. Affairs, 2016-06-20
D Anders Hove, Director, 2015-10-08

Show All Insiders (42)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on August 19, 2025, 11:42am based on SEC 13F filings Last update: August 19, 2025, 11:42am

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Armistice Capital Steven Boyd	2,236,000	$2,973,880	-50%	0.05%
2.	Citadel Investment Group Ken Griffin	249,025	$331,203		0%
3.	Renaissance Technologies Jim Simons	105,687	$140,564		0%
4.	Squarepoint Ops LLC Maxime Fortin (Cio)	97,765	$130,027		0%
5.	Millennium Management Israel Englander	81,449	$108,327	+61%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Freitag	$1.66	15,060	$24,999.60	61,213	2025-02-28	Filing
Glover	$1.66	15,061	$25,001.26	78,851	2025-02-28	Filing
Hill	$9.00	100	$900.00	4,075	2021-12-13	Filing
Hill	$9.00	100	$900.00	3,975	2021-12-13	Filing
Hill	$8.90	400	$3,560.00	3,875	2021-12-13	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Macdonald Officer, Director	$16.41	2,500	$41,025.00	570,602	2018-03-22	Filing
Macdonald Officer, Director	$16.52	2,500	$41,300.00	573,102	2018-03-21	Filing
Macdonald Officer, Director	$16.47	5,000	$82,350.00	575,602	2018-03-20	Filing
Macdonald Officer, Director	$16.66	2,500	$41,650.00	580,602	2018-03-19	Filing
Leuthner Officer, Director	$15.08	2,500	$37,700.00	70,236	2018-03-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Vanguard Group Inc	1,951,343	$2,595,286	0%
2.	Ubs Group Ag	543,021	$722,218	0%
3.	Blackrock, Inc.	514,391	$684,139	0%
4.	Geode Capital Management, Llc	417,934	$555,959	0%
5.	Blair William & Co	250,000	$332,500	0%

News See All

Click here to See All News